Page 1 of Clinical Trials for Alnylam Pharmaceuticals [SPONSOR-COLLABORATORS], 8 Total Matches
- 1CompletedLast Updated: November 29, 2007Condition(s): Respiratory Syncytial Virus Infections
- 2Active, not recruitingLast Updated: December 1, 2011Condition(s): Respiratory Syncytial Virus Infections
- 3CompletedLast Updated: May 23, 2012Condition(s): Transthyretin Mediated Amyloidosis (ATTR)
- 4Active, not recruitingLast Updated: April 20, 2012Condition(s): Elevated LDL-Cholesterol (LDL-C)
- 5RecruitingLast Updated: March 20, 2012Condition(s): TTR-mediated Amyloidosis
- 6Active, not recruitingLast Updated: December 21, 2011Condition(s): Solid Tumors
- 7CompletedLast Updated: August 23, 2011Condition(s): Solid Tumors
- 8CompletedLast Updated: June 15, 2009Condition(s): Respiratory Syncytial Virus Infections
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Alnylam+Pharmaceuticals
